Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical is planning to restructure its business with effect from March 31, 2012. Board of directors of the company will meet later this week to consider the same.

The company’s net profit for the fourth quarter ended March 31, 2012 rose 88.31% to Rs 702.00 crore as compared to Rs 372.78 crore for the quarter ended March 31, 2011. The total income has increased by 60.04% to Rs 1388.68 crore for the quarter under review from Rs 867.72 crore for the corresponding quarter of the previous year.